What is Verily?
Verily operates as a sophisticated healthcare technology entity, focusing on the synthesis of large-scale biomedical data to improve patient outcomes. By developing advanced software platforms and clinical research tools, the company bridges the gap between raw health data and actionable medical insights. Its market position is defined by its unique ability to deploy machine learning and artificial intelligence across complex clinical environments, effectively positioning itself as a leader in the digital health transformation sector. The company's operational model relies on high-level partnerships with academic medical centers and global technology conglomerates to drive innovation in health diagnostics and therapeutic development.
How much funding has Verily raised?
Verily has raised a total of $3.8B across 5 funding rounds:
Private Equity
$800M
Other Financing Round
$1B
Private Equity
$700M
Unspecified
$1B
Other Financing Round
$300M
Private Equity (2017): $800M with participation from Temasek
Other Financing Round (2019): $1B led by Temasek, Silver Lake, Ontario Teachers' Pension Plan, and Alphabet
Private Equity (2020): $700M supported by Ontario Teachers' Pension Plan, Alphabet, Inc., Silver Lake Management, L.L.C., and Temasek
Unspecified (2022): $1B featuring Alphabet
Other Financing Round (2026): $300M backed by UCHealth, University of Colorado Anschutz Medical Campus, and Alphabet
Key Investors in Verily
Alphabet
Alphabet Inc. is a multinational technology holding company that serves as the parent organization for Google and various moonshot ventures, providing the foundational infrastructure for Verily's data-driven initiatives.
Temasek
Temasek is a Singapore-based global investment firm that acts as a generational investor, focusing on long-term value creation across diverse sectors including life sciences and technology.
Silver Lake
Silver Lake is a premier global investment firm specializing in technology and technology-enabled growth businesses, providing strategic capital to support companies at various stages of development.
What's next for Verily?
With the recent influx of capital, Verily is poised to accelerate its strategic roadmap, focusing on the expansion of its clinical research systems and the refinement of its data-driven health solutions. The involvement of institutional partners like UCHealth and the University of Colorado Anschutz Medical Campus suggests a pivot toward deeper integration with frontline clinical care providers. This strategic alignment will likely facilitate the deployment of Verily's analytics tools in real-world hospital settings, enhancing the efficacy of evidence-based treatments. As the company matures, the focus will shift toward scaling these digital health platforms to achieve broader market penetration and long-term sustainability in the competitive life sciences landscape.
See full Verily company page
